Clinical efficacy of remdesivir for COVID-19 in children: A propensity-score-matched analysis

Clinical efficacy of remdesivir in children with COVID-19 is unclear. This propensity-score-matched retrospective cohort study of children with COVID-19 showed that the rate of patients achieving defervescence on Day 4 was higher in the remdesivir group than in the non-remdesivir group, but was not...

Descripción completa

Detalles Bibliográficos
Autores principales: Shoji, Kensuke, Asai, Yusuke, Akiyama, Takayuki, Tsuzuki, Shinya, Matsunaga, Nobuaki, Suzuki, Setsuko, Iwamoto, Noriko, Funaki, Takanori, Miyairi, Isao, Ohmagari, Norio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Japanese Society of Chemotherapy, Japanese Association for Infectious Diseases, and Japanese Society for Infection Prevention and Control. Published by Elsevier Ltd. 2023
Materias:
Note
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10259089/
https://www.ncbi.nlm.nih.gov/pubmed/37315843
http://dx.doi.org/10.1016/j.jiac.2023.06.006
Descripción
Sumario:Clinical efficacy of remdesivir in children with COVID-19 is unclear. This propensity-score-matched retrospective cohort study of children with COVID-19 showed that the rate of patients achieving defervescence on Day 4 was higher in the remdesivir group than in the non-remdesivir group, but was not statistically different (86.7% vs 73.3%, P = 0.333).

Ejemplares similares